HINT1 inhibits β‐catenin/TCF4, USF2 and NFκB activity in human hepatoma cells
暂无分享,去创建一个
I. Weinstein | Yu-jing Zhang | R. Santella | I. Bernard Weinstein | Regina M. Santella | Haiyang Li | Lin Wang | Yujing Zhang | Haiyang Li | Lin Wang
[1] Y. Dragan,et al. Mutational analysis of three tumor suppressor genes in two models of rat hepatocarcinogenesis , 1999, Molecular carcinogenesis.
[2] M. Buendia,et al. Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[3] S. Jacob,et al. The dual role of helix – loop – helix-zipper protein USF in ribosomal RNA gene transcription in vivo , 1997, Oncogene.
[4] B. Viollet,et al. Regulation of cdc2 gene expression by the upstream stimulatory factors (USFs) , 1999, Oncogene.
[5] K. Bhoola,et al. Genealogy, expression, and cellular function of transforming growth factor-beta. , 2003, Pharmacology & therapeutics.
[6] O. Huber,et al. The tumor suppressor Fhit acts as a repressor of β-catenin transcriptional activity , 2007, Proceedings of the National Academy of Sciences.
[7] Bonnie F. Sloane,et al. Isolation of a novel USF2 isoform: repressor of cathepsin B expression. , 2004, Gene.
[8] S. Fan,et al. β‐catenin mutation and overexpression in hepatocellular carcinoma , 2001 .
[9] A. Tsamandas,et al. TGFbeta1, TGFbeta2, and TGFbeta3 protein expression in gastric carcinomas: correlation with prognostics factors and patient survival. , 2007, The Journal of surgical research.
[10] A. Rizzino,et al. Transcription of the Transforming Growth Factor-β2 Gene Is Dependent on an E-box Located between an Essential cAMP Response Element/Activating Transcription Factor Motif and the TATA Box of the Gene* , 1996, The Journal of Biological Chemistry.
[11] R. Beauchamp,et al. Role of Smad proteins in the regulation of NF-κB by TGF-β in colon cancer cells , 2006 .
[12] L. Jeng,et al. Absence of APC gene mutation in the mutation cluster region in hepatocellular carcinoma. , 1998, Cancer letters.
[13] A. Gudkov,et al. Secreted transforming growth factor β2 activates NF-κB, blocks apoptosis, and is essential for the survival of some tumor cells , 2004 .
[14] J. Rivera,et al. Suppression of Microphthalmia Transcriptional Activity by Its Association with Protein Kinase C-interacting Protein 1 in Mast Cells* , 1999, The Journal of Biological Chemistry.
[15] Y. Konishi,et al. Different frequencies and patterns of beta-catenin mutations in hepatocellular carcinomas induced by N-nitrosodiethylamine and a choline-deficient L-amino acid-defined diet in rats. , 1999, Cancer research.
[16] J. Taub,et al. Physical and Functional Interactions between USF and Sp1 Proteins Regulate Human Deoxycytidine Kinase Promoter Activity* , 2003, Journal of Biological Chemistry.
[17] L. Matherly,et al. Transcriptional regulation of the human reduced folate carrier A1/A2 promoter: Identification of critical roles for the USF and GATA families of transcription factors. , 2005, Biochimica et biophysica acta.
[18] O. Huber,et al. The histidine triad protein Hint1 interacts with Pontin and Reptin and inhibits TCF–β-catenin-mediated transcription , 2005, Journal of Cell Science.
[19] S. Straus,et al. The cellular transcription factor USF cooperates with varicella-zoster virus immediate-early protein 62 to symmetrically activate a bidirectional viral promoter , 1994, Molecular and cellular biology.
[20] M. Masuda,et al. Growth inhibition of human hepatoma cells by acyclic retinoid is associated with induction of p21(CIP1) and inhibition of expression of cyclin D1. , 2002, Cancer research.
[21] L. Babiss,et al. Upstream stimulatory factor regulates expression of the cell cycle-dependent cyclin B1 gene promoter , 1995, Molecular and cellular biology.
[22] G. Stark,et al. Secreted transforming growth factor beta2 activates NF-kappaB, blocks apoptosis, and is essential for the survival of some tumor cells. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[23] J. Kuiper,et al. KLF2 Suppresses TGF-&bgr; Signaling in Endothelium Through Induction of Smad7 and Inhibition of AP-1 , 2007, Arteriosclerosis, thrombosis, and vascular biology.
[24] Chih-Hsin Tang,et al. Osteoblasts‐derived TGF‐β1 enhance motility and integrin upregulation through Akt, ERK, and NF‐κB‐dependent pathway in human breast cancer cells , 2008 .
[25] T. Mäkelä,et al. Interactions of Cdk7 and Kin28 with Hint/PKCI-1 and Hnt1 Histidine Triad Proteins* , 2000, The Journal of Biological Chemistry.
[26] Randall T Moon,et al. Mechanism and function of signal transduction by the Wnt/β-catenin and Wnt/Ca2+ pathways , 1999, Oncogene.
[27] Yu-Nee Lee,et al. Nonconventional Involvement of LysRS in the Molecular Mechanism of USF2 Transcriptional Activity in FcεRI-Activated Mast Cells , 2005, Molecular and Cellular Biology.
[28] Jörg Stappert,et al. β‐catenin is a target for the ubiquitin–proteasome pathway , 1997 .
[29] T. Su,et al. Deletion of histidine triad nucleotide-binding protein 1/PKC-interacting protein in mice enhances cell growth and carcinogenesis , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[30] P. Futreal,et al. Novel consensus DNA‐binding sequence for BRCA1 protein complexes , 2003, Molecular carcinogenesis.
[31] B. Viollet,et al. Immunochemical Characterization and Transacting Properties of Upstream Stimulatory Factor Isoforms (*) , 1996, The Journal of Biological Chemistry.
[32] J. Deng,et al. Overlapping roles and asymmetrical cross-regulation of the USF proteins in mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[33] H. Hermeking,et al. Evidence for a cancer-specific switch at the CDK4 promoter with loss of control by both USF and c-Myc , 2004, Oncogene.
[34] C. Knabbe,et al. TGF‐Beta Signaling in Breast Cancer , 2006, Annals of the New York Academy of Sciences.
[35] M. Colombo,et al. Epidemiology of hepatocellular carcinoma. , 1995, The Italian journal of gastroenterology.
[36] S. Reynolds,et al. Aberrant gene expression in human non small cell lung carcinoma cells exposed to demethylating agent 5-aza-2'-deoxycytidine. , 2004, Neoplasia.
[37] J. Foley,et al. Beta-catenin mutations and protein accumulation in all hepatoblastomas examined from B6C3F1 mice treated with anthraquinone or oxazepam. , 2000, Cancer research.
[38] J. M. Scholtz,et al. Energetic Implications for Protein Phosphorylation , 1996, The Journal of Biological Chemistry.
[39] S. Fan,et al. beta-Catenin mutation and overexpression in hepatocellular carcinoma: clinicopathologic and prognostic significance. , 2001, Cancer.
[40] Michael Karin,et al. NF-κB in cancer: from innocent bystander to major culprit , 2002, Nature Reviews Cancer.
[41] Michael Karin,et al. NF-kappaB in cancer: from innocent bystander to major culprit. , 2002, Nature reviews. Cancer.
[42] A. Rizzino,et al. Transcriptional regulation of the transforming growth factor-β2 gene in glioblastoma cells , 2001, In Vitro Cellular & Developmental Biology - Animal.
[43] M. Karin,et al. IKKα is a critical coregulator of a Smad4-independent TGFβ-Smad2/3 signaling pathway that controls keratinocyte differentiation , 2008, Proceedings of the National Academy of Sciences.
[44] J. Shimazaki,et al. Expression and prognostic roles of beta-catenin in hepatocellular carcinoma: correlation with tumor progression and postoperative survival. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.
[45] K. Jungermann,et al. The upstream stimulatory factor-2a inhibits plasminogen activator inhibitor-1 gene expression by binding to a promoter element adjacent to the hypoxia-inducible factor-1 binding site. , 2001, Blood.
[46] I. Weinstein,et al. Hint1 inhibits growth and activator protein-1 activity in human colon cancer cells. , 2007, Cancer research.
[47] S. Vaulont,et al. Differential Roles of Upstream Stimulatory Factors 1 and 2 in the Transcriptional Response of Liver Genes to Glucose* , 1998, The Journal of Biological Chemistry.
[48] Haiyang Li,et al. Hint1 is a haplo-insufficient tumor suppressor in mice , 2006, Oncogene.
[49] R Kemler,et al. beta-catenin is a target for the ubiquitin-proteasome pathway. , 1997, The EMBO journal.
[50] K. Jungermann,et al. Modulation of glucokinase expression by hypoxia-inducible factor 1 and upstream stimulatory factor 2 in primary rat hepatocytes , 2004, Biological chemistry.
[51] G. Stark,et al. Secretion of cytokines and growth factors as a general cause of constitutive NFκB activation in cancer , 2004, Oncogene.
[52] A. Tsamandas,et al. TGFβ1, TGFβ2, and TGFβ3 Protein Expression in Gastric Carcinomas: Correlation with Prognostics Factors and Patient Survival , 2007 .
[53] P. Higgins,et al. Upstream stimulatory factor regulates E box‐dependent PAI‐1 transcription in human epidermal keratinocytes , 2005, Journal of cellular physiology.